Literature DB >> 2916544

Heart disease risk factors, diabetes, and prostatic cancer in an adult community.

M M Thompson1, C Garland, E Barrett-Connor, K T Khaw, N J Friedlander, D L Wingard.   

Abstract

The authors studied the association between heart disease and prostatic cancer in Rancho Bernardo, California, from August 1972 to June 1987. During a 14-year follow-up of 1,776 men aged 50-84 years, 100 cases of prostatic cancer were identified, of which 54 were incident. Systolic blood pressure, cigarette smoking, and plasma cholesterol levels in cases did not differ from those in noncases. After adjustment for age and on multivariate analysis, incident cases of prostatic cancer had a nonsignificantly higher frequency of reported heart disease at baseline. History of diabetes was inversely associated with total prostatic cancer (age-adjusted estimated relative risk = 0.2, 90% confidence interval: 0.0-0.8; multivariate-adjusted relative risk = 0.3, 90% confidence interval: 0.1-1.0). The association between heart disease and prostatic cancer is compatible with diagnostic detection bias. The inverse association between diabetes and prostatic cancer is compatible with a cancer-promoting role for endogenous testosterone, the level of which is lower in diabetics, or a risk-reducing effect of antidiabetic diet or drug therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2916544     DOI: 10.1093/oxfordjournals.aje.a115162

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Milk and dairy consumption among men with prostate cancer and risk of metastases and prostate cancer death.

Authors:  Andreas Pettersson; Julie L Kasperzyk; Stacey A Kenfield; Erin L Richman; June M Chan; Walter C Willett; Meir J Stampfer; Lorelei A Mucci; Edward L Giovannucci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-02-07       Impact factor: 4.254

Review 2.  Nutrition and prostate cancer.

Authors:  L N Kolonel
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

3.  Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial.

Authors:  Elizabeth A Platz; Cathee Till; Phyllis J Goodman; Howard L Parnes; William D Figg; Demetrius Albanes; Marian L Neuhouser; Eric A Klein; Ian M Thompson; Alan R Kristal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

Review 4.  Cholesterol and prostate cancer.

Authors:  Kristine Pelton; Michael R Freeman; Keith R Solomon
Journal:  Curr Opin Pharmacol       Date:  2012-07-21       Impact factor: 5.547

5.  Serum total and HDL cholesterol and risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-09-14       Impact factor: 2.506

6.  Shared common variants in prostate cancer and blood lipids.

Authors:  Ole A Andreassen; Verena Zuber; Wesley K Thompson; Andrew J Schork; Francesco Bettella; Srdjan Djurovic; Rahul S Desikan; Ian G Mills; Anders M Dale
Journal:  Int J Epidemiol       Date:  2014-04-30       Impact factor: 7.196

7.  Examining the relationship between obesity and prostate cancer.

Authors:  Stephen J Freedland; William J Aronson
Journal:  Rev Urol       Date:  2004

8.  Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia.

Authors:  A P Berger; M Deibl; E J Halpern; M Lechleitner; J Bektic; W Horninger; G Fritsche; H Steiner; A Pelzer; G Bartsch; F Frauscher
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

9.  Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies.

Authors:  Michael Huncharek; K Sue Haddock; Rodney Reid; Bruce Kupelnick
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

10.  Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

Authors:  J Kellogg Parsons; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  BJU Int       Date:  2007-11-13       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.